AE Wealth Management’s FT Vest US Equity Moderate Buffer ETF October GOCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36K Buy
867
+267
+45% +$10.9K ﹤0.01% 2153
2026
Q1
$23.2K Buy
600
+548
+1,054% +$21.6K ﹤0.01% 2122
2025
Q4
$2.04K Buy
+52
New +$2.02K ﹤0.01% 2333
2025
Q2
Sell
-43,490
Closed -$1.49M 2204
2025
Q1
$1.49M Sell
43,490
-87
-0.2% -$3.06K 0.01% 607
2024
Q4
$1.52M Sell
43,577
-1,015
-2% -$35.5K 0.01% 607
2024
Q3
$1.55M Sell
44,592
-843
-2% -$29K 0.01% 610
2024
Q2
$1.55M Sell
45,435
-8,958
-16% -$302K 0.02% 590
2024
Q1
$1.82M Sell
54,393
-16,886
-24% -$556K 0.02% 518
2023
Q4
$2.33M Buy
+71,279
New +$2.24M 0.01% 850

Other funds holding GOCT

AE Wealth Management's GOCT Position: Q2 2026 in Review

AE Wealth Management increased its FT Vest US Equity Moderate Buffer ETF October (GOCT) stake by 45% in Q2 2026, buying an estimated $10.9K and bringing the position to 867 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #2153.

AE Wealth Management first reported a position in GOCT in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.33M in Q4 2023. 107 funds tracked by Wall St. Rank hold GOCT as of Q2 2026.

  • AE Wealth Management held 867 shares of FT Vest US Equity Moderate Buffer ETF October worth $36K as of Q2 2026.
  • AE Wealth Management bought 267 FT Vest US Equity Moderate Buffer ETF October shares in Q2 2026, an estimated $10.9K.
  • FT Vest US Equity Moderate Buffer ETF October made up ﹤0.01% of AE Wealth Management's portfolio in Q2 2026, its #2153 holding.
  • AE Wealth Management first reported a position in FT Vest US Equity Moderate Buffer ETF October in Q4 2023 and has held it in 9 quarters since.
  • AE Wealth Management's FT Vest US Equity Moderate Buffer ETF October position peaked at $2.33M in Q4 2023.
  • 107 funds tracked by Wall St. Rank held FT Vest US Equity Moderate Buffer ETF October as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.